Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome
{{output}}
The Plasmodium falciparum proteasome constitutes a promising antimalarial target, with multiple chemotypes potently and selectively inhibiting parasite proliferation and synergizing with the first-line artemisinin drugs, including against artemisinin-resistant... ...
